reports
Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media...
Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media and Communications Conference SAN JOSE, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Infinera (NASDAQ: INFN) announced today that it will participate in the following webcasted investor conference: J.P. Morgan 2024 Global Technology, Media and Communications ConferenceDate: Wednesday, May 22, 2024Presentation: 8:40am EDT / 5:40am PDTSpeaker: Nancy Erba, CFOWebcast: investors.infinera.com and click on “Events” Contacts: Infinera Media:Anna VueTel. +1 (916) 595-8157 Infinera Investors:Amitabh Passi, Head of Investor Rela...
Infinera Names Regan MacPherson Chief Legal Officer and Corporate Secr...
Infinera Names Regan MacPherson Chief Legal Officer and Corporate Secretary SAN JOSE, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Infinera (Nasdaq: INFN) announced today that Regan MacPherson has been named Chief Legal Officer and Corporate Secretary, effective May 18. Ms. MacPherson will report to Infinera Chief Executive Officer David Heard and will oversee the company’s global legal strategy and corporate governance matters and policies. Ms. MacPherson succeeds David Teichmann, whose distinguished tenure with the company includes trusted and empathetic leadership during a period marked by...
CervoMed to Appoint William Elder as Chief Financial Officer
CervoMed to Appoint William Elder as Chief Financial Officer BOSTON, May 20, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced the appointment of William (Bill) Elder as Chief Financial Officer, effective June 1, 2024. Mr. Elder will continue to serve as General Counsel and Corporate Secretary. He will succeed William Tanner who has served as Chief Financial Officer to CervoMed and its predecessor, EIP Pharma, since September 2022. Mr. Tanner will continue as a consultant t...
- David Carlson
- David Nierengarten
- Dennis Pak
- Laura Chico
- Martin Fan
- Ritika Das
- Robert Driscoll
- Sam Ravina
El Pollo Loco Brings Fan-Favorite Stuffed Quesadillas Back with New Se...
El Pollo Loco Brings Fan-Favorite Stuffed Quesadillas Back with New Seasonal Flavors Satisfy Your Cravings with Our Three Delicious Stuffed Quesadillas—They Make The Ultimate Grab-and-Go Meal for Those Who Want Convenience without Sacrificing Flavor COSTA MESA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- El Pollo Loco, Inc. ("El Pollo Loco" or "Company") (Nasdaq: LOCO), the nation's leading restaurant chain specializing in fire-grilled chicken, is bringing back two fan-favorite seasonal Stuffed Quesadilla flavors to join the menu for a limited time, alongside the permanent Chicken Avocado ...
REV Group to Release Second Quarter 2024 Earnings on Wednesday, June 5...
BROOKFIELD, Wis.--(BUSINESS WIRE)-- REV Group, Inc. (NYSE: REVG), today announced that it is planning to release its second quarter fiscal 2024 results before market open on Wednesday, June 5, 2024. The results will be discussed during a live webcast later that morning on June 5, 2024, beginning at 10:00 a.m. ET. To access the webcast, investors should go to at least 15 minutes prior to the event. Slides for the webcast will be available on the website before the start of the call. The conference call can also be accessed by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international...
Infinera Achieves New Benchmark Delivering 83.6 Tbps Data Transmission...
Infinera Achieves New Benchmark Delivering 83.6 Tbps Data Transmission on Simulated Telstra InfraCo Intercity Links with Infinera's Latest Optical Technology SAN JOSE, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Infinera (Nasdaq: INFN) announced today the successful completion of desktop simulated network evaluations using Telstra InfraCo’s Australian intercity optical fibre. The desktop evaluations were conducted on two simulated links − the 1,240-km link between Melbourne and Sydney and the 3,937-km link between Perth and Sydney − achieving a groundbreaking fibre capacity of 83.6 Tbps and ...
Celcuity Inc. Reports First Quarter Financial Results and Provides Cor...
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update The Phase 3 VIKTORIA-1 trial remains on track to report topline data from PIK3CA wild type patient sub-group in the second half of 2024First patient dosed in a Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer $177.7 million in cash, cash equivalents and short-term investments expected to provide runway into the first half of 2026 Management to host webcast and conference call today, May 15, 2024, at 4:30 p.m. E...
CervoMed Reports First Quarter 2024 Financial Results and Provides Cor...
CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates - CervoMed on track to complete enrollment in 2Q 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with dementia with Lewy bodies (DLB); topline data expected in 4Q 2024- - Completed up to $149.4 million private placement with leading healthcare investors in early 2Q 2024 - BOSTON, May 15, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today reported its financial resul...
Super Sistem Selects Infinera’s GX Series for SSBS Cable System to Exp...
Super Sistem Selects Infinera’s GX Series for SSBS Cable System to Expand Connectivity to Indonesia SAN JOSE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Infinera (Nasdaq: INFN) announced today that Indonesian network operator Super Sistem Group (Super Sistem) has selected Infinera’s and ICE6 800G coherent solution to power the Super Sistem Batam Singapore (SSBS) Cable System connecting Batam to Singapore. The SSBS is a subsea fiber optic cable system and is part of a broader initiative to bring broadband to underserved communities. The deployment of Infinera’s solution will help to increas...
- Wedbush Research
BLUE BLUEBIRD BIO INC.
TPH TRI POINTE HOMES INC.
TOL TOLL BROTHERS INC.
MTH MERITAGE HOMES CORPORATION
LGIH LGI HOMES INC.
LEN LENNAR CORPORATION CLASS A
KBH KB HOME
JACK JACK IN THE BOX INC.
FATE FATE THERAPEUTICS INC
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
AZO AUTOZONE INC.
DHI D.R. HORTON INC.
TMHC TAYLOR MORRISON HOME CORPORATION
ORLY O'REILLY AUTOMOTIVE INC.
ACET ADICET BIO INC
BEAM BEAM THERAPEUTICS
COGT COGENT BIOSCIENCES INC
DFH DREAM FINDERS HOMES
NUVB NUVATION BIO INC (A)
TSVT 2SEVENTY BIO INC
GMTX GEMINI THERAPEUTICS INC
PEPG PEPGEN INC
SDHC SMITH DOUGLAS HOMES CORP
- Brian Violino
- Jay McCanless
Infinera Corporation Reports Preliminary First Quarter 2024 Financial ...
Infinera Corporation Reports Preliminary First Quarter 2024 Financial Results SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) today released preliminary financial results for its first quarter ended March 30, 2024. Although presented with numerical specificity, all amounts in this press release are preliminary and based on management’s current expectations as of the date of this press release. These results are subject to all aspects of the final quarterly review process and may change as a result of new information that arises, or new determinations...
CompoSecure General Counsel Honored by NJBIZ Leaders in Law Awards
CompoSecure General Counsel Honored by NJBIZ Leaders in Law Awards Steve Feder was recognized for his exceptional legal expertise and acumen SOMERSET, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced Steve Feder, General Counsel and Corporate Secretary, has been named an honoree in the prestigious NJBIZ Leaders in Law awards for 2024. The award ceremony took place today at The Palace at Somerset Park, celebrating the achievements of outstanding legal professionals. “Steve's appointment as an...
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and ...
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights WATERTOWN, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics (AP3), today reported financial results for the first quarter en...
- Wedbush Research
BLUE BLUEBIRD BIO INC.
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TRIP TRIPADVISOR INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MELI MERCADOLIBRE INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
EXPE EXPEDIA GROUP INC.
AXTI AXT INC.
OSTK OVERSTOCK.COM INC.
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
HPE HEWLETT PACKARD ENTERPRISE CO.
SE SEA ADS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
BKNG BOOKING HOLDINGS INC.
AVGO BROADCOM INC.
STRO SUTRO BIOPHARMA
LYFT LYFT
PINS PINTEREST INC. CLASS A
UBER UBER TECHNOLOGIES INC.
DELL DELL TECHNOLOGIES INC CLASS C
GBIO GENERATION BIO
DASH DOORDASH
ABNB AIRBNB INC. CLASS A
MRVL MARVELL TECHNOLOGY INC
STX SEAGATE TECHNOLOGY HLDGS PLC
IKNA IKENA ONCOLOGY INC
AVTE AEROVATE THERAPEUTICS INC
DBD DIEBOLD NIXDORF INCORPORATED
- Laura Chico
Infinera to Announce Preliminary Fiscal First Quarter 2024 Financial R...
Infinera to Announce Preliminary Fiscal First Quarter 2024 Financial Results on May 14, 2024 SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) announced today that it will release its preliminary financial results for the first quarter of fiscal 2024 ended March 30, 2024, after the market closes on May 14, 2024. An investment community conference call to discuss these results and Infinera’s outlook for the second quarter of fiscal 2024 will be held the same day at 5:00 p.m. ET/2:00 p.m. PT and will be accessible live and on an archived basis as fo...
Aerovate Therapeutics Announces First Quarter Financial Results and Bu...
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH) Enrollment continues into the Phase 3 portion of the IMPAHCT trial of AV-101 Poster to be presented with baseline characteristics of the Phase 2b portion of the IMPAHCT trial at the ATS 2024 Conference on May 21 Cash runway into 2026, based on our current operating plan WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeuti...
Infinera Corporation Fourth Quarter and Fiscal 2023 Summary of Key Fin...
Infinera Corporation Fourth Quarter and Fiscal 2023 Summary of Key Financial Results SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) has issued a press release with a summary of key financial results for the fourth quarter and fiscal year ended December 30, 2023. The press release is also published on Infinera’s Investor Relations website. GAAP revenue for the quarter was $453.5 million compared to $392.4 million in the third quarter of 2023 and $485.9 million in the fourth quarter of 2022. GAAP gross margin for the quarter was 38.6% compared to 40...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.